Developed by patient advocates and lawyers practicing FDA law, this course highlights salient case studies and opportunities for collaboration to help patient organizations develop and diversify strategies for engaging with the FDA throughout the drug development process. The program will equip patient-focused policy professionals and advocates working in the legal and regulatory sectors with a critical source of contemporary, accessible, and applicable understanding of the legal tools and strategies to enhance their interactions with FDA and therapy innovators. Registration for this two-day program is only $49. For more information, visit the website.
Milken Institute School of Public Health At the George Washington University
950 New Hampshire Ave, NW
Washington, DC 20052United States
Wednesday, November 7, 2018 to Thursday, November 8, 2018